A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Ischemic Stroke

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

BeiJing Tiantan Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (YongJun Wang, Doctor) · yongjunwang1962@gmail.com · 010-59978538

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE2

Meizhou, China · Luoyang, China

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE2, PHASE3

Long Beach, United States · Sacramento, United States

Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE3

Linfen, China

Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE3

Chuzhou, China · Longyan, China